Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Itsuo Gorai"'
Autor:
Eiji Itoi, Yasuo Ohashi, Hajime Orimo, Itsuo Gorai, Satoshi Mori, Toshitaka Nakamura, Hiroaki Ohta, Masataka Shiraki, Nobuaki Miyakawa, Masao Fukunaga, Toshitsugu Sugimoto, Yukari Uemura, Hiroshi Hagino, Shiro Tanaka, Takayuki Hosoi, Teruhiko Miyazaki
Publikováno v:
Journal of Bone and Mineral Metabolism. 35:385-395
The aim of this study was to investigate the efficacy of concurrent treatment with vitamin K2 and risedronate compared with treatment with risedronate alone in patients with osteoporosis and to explore subsets of patients for which concurrent treatme
Autor:
Takami Miki, Hiroshi Ochi, Kousei Yoh, Masahiko Takada, Hiroaki Ohta, Itsuo Gorai, Toshitsugu Sugimoto, Hiroshi Sato, Ginger D. Constantine, Arkadi Chines, Akira Itabashi, Hideki Mizunuma
Publikováno v:
Journal of Bone and Mineral Metabolism. 33:61-72
This study examined whether the global clinical data for bazedoxifene could be extrapolated to a Japanese population by evaluating the results of a phase 2 study in postmenopausal Japanese women with osteoporosis as compared to those of a pivotal, ph
Autor:
Toshio Matsumoto, Ko Watanabe, Toshiyuki Yoneda, Itsuo Gorai, Teruki Sone, Hideo Takami, Toshitaka Nakamura, Sakae Tanaka, Taisuke Osakabe, Masao Fukunaga, Shigeyuki Matsui, Toshitsugu Sugimoto, Masako Ito, Hideki Yoshikawa, Takayuki Hosoi, Tetsuo Nakano, Takami Miki, Yoshiya Tanaka, Masataka Shiraki
Publikováno v:
The Journal of Clinical Endocrinology and Metabolism
Context: Denosumab 60 mg sc injection every 6 months for 36 months was well tolerated and effective in reducing the incidence of vertebral, nonvertebral, and hip fracture in predominantly Caucasian postmenopausal women with osteoporosis. Objective: T
Autor:
Toshiyuki Yoneda, Itsuo Gorai, Masao Fukunaga, Takayuki Hosoi, Naoto Endo, Saeko Fujiwara, Hiroshi Hagino, Satoshi Soen, Hiroaki Ohta, Tatsushi Tomomitsu, Toshitsugu Sugimoto, Teruki Sone, Masataka Shiraki
Publikováno v:
Journal of Bone and Mineral Metabolism. 31:247-257
In 1995, the Japanese Society for Bone and Mineral Metabolism (now the Japanese Society for Bone and Mineral Research) established the Osteoporosis Diagnostic Criteria Review Committee. Following discussion held at the 13th scientific meeting of the
Autor:
Shiro, Tanaka, Teruhiko, Miyazaki, Yukari, Uemura, Nobuaki, Miyakawa, Itsuo, Gorai, Toshitaka, Nakamura, Masao, Fukunaga, Yasuo, Ohashi, Hiroaki, Ohta, Satoshi, Mori, Hiroshi, Hagino, Takayuki, Hosoi, Toshitsugu, Sugimoto, Eiji, Itoi, Hajime, Orimo, Masataka, Shiraki
Publikováno v:
Journal of bone and mineral metabolism. 35(4)
The aim of this study was to investigate the efficacy of concurrent treatment with vitamin K
Autor:
Kousei Yoh, Hiroshi Ochi, Hiroaki Ohta, Ginger D. Constantine, Masahiko Takada, Hideki Mizunuma, Hiroshi Sato, Akira Itabashi, Toshitsugu Sugimoto, Takami Miki, Arkadi Chines, Itsuo Gorai
Publikováno v:
Journal of Bone and Mineral Research. 26:519-529
This randomized, double-blind, placebo-controlled, dose-response late phase 2 study evaluated the efficacy and safety of bazedoxifene in postmenopausal Japanese women 85 years of age or younger with osteoporosis. Eligible subjects received daily trea
Autor:
Tatsuhiko Kuroda, Toshihiko Yamashita, Eiji Itoi, Toshitaka Nakamura, Naohito Fujinawa, Kunio Takaoka, Masataka Shiraki, Naoto Endo, Hideki Mizunuma, Yoshiki Nishizawa, Hajime Orimo, Yasuo Ohashi, Nobuaki Miyakawa, Akira Itabashi, Shigeto Morimoto, Toshitsugu Sugimoto, Yukari Tanaka, Hiroaki Ohta, Shiro Tanaka, Akiko Ishizuka, Masao Fukunaga, Takayuki Hosoi, Kazumasa Tanzawa, Satoshi Mori, Hideaki Kishimoto, Itsuo Gorai
Publikováno v:
Journal of Bone and Mineral Metabolism. 29:37-43
The aim of osteoporosis treatment is to prevent future fractures. Although concurrent treatment has been used very frequently for osteoporosis in clinical practice, there are no data on accurate and verified effectiveness of concurrent treatment for
Publikováno v:
Climacteric. 13:72-83
This 2-year study compared 0.5 and 1.0 mg oral estradiol (E(2)), with or without levonorgestrel (LNG), for the treatment of postmenopausal osteoporosis in Japanese women.Japanese women with osteoporosis after natural menopause or bilateral oophorecto
Publikováno v:
Journal of Bone and Mineral Metabolism. 28:176-184
Patients who are diagnosed with osteoporosis and beginning treatment often discontinue their osteoporosis medication relatively early after the start of treatment because of their poor recognition of fracture risk and the asymptomatic nature of osteo
Autor:
S. Fujiwara, Helena Johansson, Hajime Orimo, Toshitaka Nakamura, Anders Odén, Itsuo Gorai, Takayuki Hosoi, John A. Kanis
Publikováno v:
Osteoporosis International
Summary The present study estimated the 10-year probability using the Japanese version of WHO fracture risk assessment tool (FRAX™) in order to determine fracture probabilities that correspond to intervention thresholds currently used in Japan and